Cost-effectiveness of a chronic disease management model for cirrhosis: Analysis of a randomized controlled trial

2018 ◽  
Vol 33 (9) ◽  
pp. 1634-1640 ◽  
Author(s):  
Alan J Wigg ◽  
Jong K Chin ◽  
Kate R Muller ◽  
Jeyamani Ramachandran ◽  
Richard J Woodman ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Chronic Disease ◽  
Cost Effectiveness ◽  
Disease Management ◽  
Chronic Disease Management ◽  
Controlled Trial ◽  
Management Model ◽  
Randomized Controlled

scholarly journals DIVERT-Collaboration Action Research and Evaluation (CARE) Trial Protocol: a multiprovincial pragmatic cluster randomised trial of cardiorespiratory management in home care

BMJ Open ◽  
2019 ◽  
Vol 9 (12) ◽  
pp. e030301 ◽  
Author(s):  
Andrew P Costa ◽  
Connie Schumacher ◽  
Aaron Jones ◽  
Darly Dash ◽  
Graham Campbell ◽  
...  
Keyword(s):  
Chronic Disease ◽  
Cost Effectiveness ◽  
Action Research ◽  
Disease Management ◽  
Home Care ◽  
Chronic Disease Management ◽  
Management Model ◽  
Care Providers ◽  
Cluster Randomised ◽  
The Difference

IntroductionHome care clients are increasingly medically complex, have limited access to effective chronic disease management and have very high emergency department (ED) visitation rates. There is a need for more appropriate and targeted supportive chronic disease management for home care clients. We aim to evaluate the effectiveness and preliminary cost effectiveness of a targeted, person-centred cardiorespiratory management model.Methods and analysisThe Detection of Indicators and Vulnerabilities of Emergency Room Trips (DIVERT) — Collaboration Action Research and Evaluation (CARE) trial is a pragmatic, cluster-randomised, multicentre superiority trial of a flexible multicomponent cardiorespiratory management model based on the best practice guidelines. The trial will be conducted in partnership with three regional, public-sector, home care providers across Canada. The primary outcome of the trial is the difference in time to first unplanned ED visit (hazard rate) within 6 months. Additional secondary outcomes are to identify changes in patient activation, changes in cardiorespiratory symptom frequencies and cost effectiveness over 6 months. We will also investigate the difference in the number of unplanned ED visits, number of inpatient hospitalisations and changes in health-related quality of life. Multilevel proportional hazard and generalised linear models will be used to test the primary and secondary hypotheses. Sample size simulations indicate that enrolling 1100 home care clients across 36 clusters (home care caseloads) will yield a power of 81% given an HR of 0.75.Ethics and disseminationEthics approval was obtained from the Hamilton Integrated Research Ethics Board as well as each participating site’s ethics board. Results will be submitted for publication in peer-reviewed journals and for presentation at relevant conferences. Home care service partners will also be informed of the study’s results. The results will be used to inform future support strategies for older adults receiving home care services.Trial registration numberNCT03012256.

Sign in / Sign up

Export Citation Format

Share Document